Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00561834 · ClinicalTrials.gov registry record · Phase 1
Ranibizumab Therapy for Non-arteritic Ischemic Optic Neuropathy
A Phase 1 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 1
- Development phase
- 2
- Enrollment target
NCT00561834 is a Phase 1 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 2 participants.
The verdict
NCT00561834, a Phase 1 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to explore the safety and efficacy of ranibizumab to treat non-arteritic ischemic optic neuropathy based on clinical and anatomical findings.
Interventions
- DRUG ranibizumab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2007-11 |
| Est. Completion | 2009-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00561834
The ClinicalTrials.gov registry entry for NCT00561834 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ranibizumab is the first listed.
NCT00561834 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00561834 about?
NCT00561834 is a clinical study titled "Ranibizumab Therapy for Non-arteritic Ischemic Optic Neuropathy". The purpose of this study is to explore the safety and efficacy of ranibizumab to treat non-arteritic ischemic optic neuropathy based on clinical and anatomical findings.
What is the current status of trial NCT00561834?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 2 participants. The study started on 2007-11. Estimated completion is 2009-04.
What interventions are being tested in trial NCT00561834?
The interventions under investigation include: ranibizumab (DRUG).
Who is sponsoring clinical trial NCT00561834?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.